Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8

被引：245

作者：

Kukulski F. ^{[1
]}

Lévesque S.A. ^{[1
]}

Lavoie É.G. ^{[1
]}

Lecka J. ^{[1
]}

Bigonnesse F. ^{[1
]}

Knowles A.F. ^{[2
]}

Robson S.C. ^{[3
]}

Kirley T.L. ^{[4
]}

Sévigny J. ^{[1
]}

机构：

[1] Ctr. Rech. en Rhumatologie/Immunol., Centre Hospitalier de l'Univ. Laval, Ste-Foy, Que.

[2] Dept. of Chemistry and Biochemistry, San Diego State University, San Diego, CA

[3] Department of Medicine, Beth Israel Deaconess Medical Ctr., Harvard Medical School, Boston, MA

[4] Dept. of Pharmacol./Cell Biophysics, College of Medicine, University of Cincinanati, Cincinnati, OH

来源：

Purinergic Signalling | 2005年 / 1卷 / 2期

关键词：

ATP; ATPase; Ectonucleotidase; Extracellular nucleotide; P1; receptor; P2;

D O I：

10.1007/s11302-005-6217-x

中图分类号：

学科分类号：

摘要：

Nucleoside triphosphate diphosphohydrolases 1, 2, 3 and 8 (NTPDases 1, 2, 3 and 8) are the dominant ectonucleotidases and thereby expected to play important roles in nucleotide signaling. Distinct biochemical characteristics of individual NTPDases should allow them to regulate P2 receptor activation differentially. Therefore, the biochemical and kinetic properties of these enzymes were compared. NTPDases 1, 2, 3 and 8 efficiently hydrolyzed ATP and UTP with K m values in the micromolar range, indicating that they should terminate the effects exerted by these nucleotide agonists at P2X1-7 and P2Y2,4,11 receptors. Since NTPDase1 does not allow accumulation of ADP, it should terminate the activation of P2Y1,12,13 receptors far more efficiently than the other NTPDases. In contrast, NTPDases 2, 3 and 8 are expected to promote the activation of ADP specific receptors, because in the presence of ATP they produce a sustained (NTPDase2) or transient (NTPDases 3 and 8) accumulation of ADP. Interestingly, all plasma membrane NTPDases dephosphorylate UTP with a significant accumulation of UDP, favoring P2Y6 receptor activation. NTPDases differ in divalent cation and pH dependence, although all are active in the pH range of 7.0-8.5. Various NTPDases may also distinctly affect formation of extracellular adenosine and therefore adenosine receptor-mediated responses, since they generate different amounts of the substrate (AMP) and inhibitor (ADP) of ecto-5′-nucleotidase, the rate limiting enzyme in the production of adenosine. Taken together, these data indicate that plasma membrane NTPDases hydrolyze nucleotides in a distinctive manner and may therefore differentially regulate P2 and adenosine receptor signaling. © Springer 2005.

引用

页码：193 / 204

页数：11

共 45 条

[1]

Zimmermann H., Ectonucleotidases: Some recent developments and note on nomenclature, Drug Dev. Res., 52, pp. 44-56, (2001)

[2]

Muller C.E., P2-pyrimidinergic receptors and their ligands, Curr. Pharm. Des., 8, pp. 2353-2369, (2002)

[3]

North R.A., Molecular physiology of P2X receptors, Physiol. Rev., 82, pp. 1013-1067, (2002)

[4]

Picher M., Sevigny J., D'Orleans-Juste P., Beaudoin A.R., Hydrolysis of P2-purinoceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolase, Biochem. Pharmacol., 51, pp. 1453-1460, (1996)

[5]

Smith T.M., Kirley T.L., Site-directed mutagenesis of a human brain ecto-apyrase: Evidence that the E-type ATPases are related to the actin/heat shock 70/sugar kinase superfamily, Biochemistry, 38, pp. 321-328, (1999)

[6]

Mateo I., Harden T.K., Boyer J.L., Functional expression of a cDNA encoding a human ecto-ATPase, Br. J. Pharmacol., 128, pp. 396-402, (1999)

[7]

Lavoie E.G., Kukulski F., Levesque S.A., Et al., Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-3, Biochem. Pharmacol., 67, pp. 1917-1926, (2004)

[8]

Bigonnesse F., Levesque S.A., Kukulski F., Et al., Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8, Biochemistry, 43, pp. 5511-5519, (2004)

[9]

Wang T.F., Guidotti G., Golgi localization and functional expression of human uridine diphosphatase, J. Biol. Chem., 273, pp. 11392-11399, (1998)

[10]

Biederbick A., Kosan C., Kunz J., Elsasser H.P., First apyrase splice variants have different enzymatic properties, J. Biol. Chem., 275, pp. 19018-19024, (2000)

← 1 2 3 4 5 →